Nursing Interventions Related to the Need for Oxygenation in Severe COVID-19 Disease in Hospitalized Adults: A Retrospective Study
- PMID: 39449464
- PMCID: PMC11503258
- DOI: 10.3390/nursrep14040227
Nursing Interventions Related to the Need for Oxygenation in Severe COVID-19 Disease in Hospitalized Adults: A Retrospective Study
Abstract
COVID-19 affects the respiratory system, reducing the oxygen saturation level, leading to hypoxemia and increasing the metabolic oxygenation need.
Objective: To describe the nursing interventions related to the need for oxygenation in hospitalized adults with severe COVID-19 disease in the Intensive Care Unit.
Method: This was an observational, retrospective and descriptive study in a population of 2205 patients with a convenience sample of n = 430 and based on the North American Nursing Diagnosis Association (NANDA), the Nursing Interventions Classification (NIC) and the Nursing Outcomes Classification (NOC). The analysis was performed with a non-parametric test to determine the association between the nursing interventions and the need for oxygenation.
Results: The findings are aimed at improving nursing interventions with statistical associations as follow: oxygen therapy (p < 0.000), airway suctioning (p < 0.000), airway management (p = 0.029), invasive mechanical ventilation (p < 0.000) and non-invasive mechanical ventilation (p = 0.022). NOC taxonomy expected outcomes in ventilation, 34% (146), alteration in gas exchange, 33.7% (145), and respiratory status, 558.9% (253), were severely compromised.
Conclusions: The nursing interventions to maintain the respiratory status are focused on airway care and oxygen therapy in order to increase the oxygen saturation level and decrease the severity of the need for oxygenation.
Keywords: COVID-19; need for oxygenation; nursing care; nursing diagnosis; nursing interventions classification; nursing outcomes classification.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Use of the North American Nursing Diagnosis Association taxonomies, Nursing Intervention Classification, Nursing Outcomes Classification and NANDA-NIC-NOC linkage in cardiac rehabilitation.Monaldi Arch Chest Dis. 2019 May 21;89(2). doi: 10.4081/monaldi.2019.1060. Monaldi Arch Chest Dis. 2019. PMID: 31122006
-
NANDA-I, NOC, and NIC linkages to SARS-CoV-2 (COVID-19): Part 2. Individual response.Int J Nurs Knowl. 2021 Jan;32(1):68-83. doi: 10.1111/2047-3095.12307. Epub 2020 Nov 10. Int J Nurs Knowl. 2021. PMID: 33169943
-
NOC/NIC Linkages to NANDA-I for Continence Care of Elderly People with Urinary Incontinence in Nursing Homes: A Systematic Review.Florence Nightingale Hemsire Derg. 2019 Oct 1;27(3):284-303. doi: 10.26650/FNJN386150. eCollection 2019 Oct. Florence Nightingale Hemsire Derg. 2019. PMID: 34267982 Free PMC article. Review.
-
Remdesivir for the treatment of COVID-19.Cochrane Database Syst Rev. 2021 Aug 5;8(8):CD014962. doi: 10.1002/14651858.CD014962. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2023 Jan 25;1:CD014962. doi: 10.1002/14651858.CD014962.pub2. PMID: 34350582 Free PMC article. Updated.
References
-
- Secretaria de Salud COVID-19 México, Información General. México. 2023. [(accessed on 25 November 2023)]. Available online: https://datos.covid-19.conacyt.mx/
-
- Gupta S., Hayek S.S., Wang W., Chan L., Mathews K.S., Melamed M.L., Brenner S.K., Leonberg-Yoo A., Schenck E.J., Radbel J., et al. Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the US. JAMA Intern. Med. 2020;180:1436–1447. doi: 10.1001/jamainternmed.2020.3596. - DOI - PMC - PubMed
-
- LDomínguez-Ramírez L., Sosa-Jurado F., Díaz-Sampayo G., Solis-Tejeda I., Rodríguez-Pérez F., Pelayo R., Santos-López G., Cortes-Hernandez P. Age and Comorbidities as Risk Factors for Severe COVID-19 in Mexico, before, during and after Massive Vaccination. Vaccines. 2023;11:1676. doi: 10.3390/vaccines11111676. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources